1. Home
  2. GURE vs CHRO Comparison

GURE vs CHRO Comparison

Compare GURE & CHRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GURE
  • CHRO
  • Stock Information
  • Founded
  • GURE 2006
  • CHRO 2002
  • Country
  • GURE China
  • CHRO United States
  • Employees
  • GURE N/A
  • CHRO N/A
  • Industry
  • GURE Major Chemicals
  • CHRO
  • Sector
  • GURE Industrials
  • CHRO
  • Exchange
  • GURE Nasdaq
  • CHRO Nasdaq
  • Market Cap
  • GURE 8.5M
  • CHRO 8.4M
  • IPO Year
  • GURE 1992
  • CHRO 2024
  • Fundamental
  • Price
  • GURE $0.62
  • CHRO $1.14
  • Analyst Decision
  • GURE
  • CHRO Strong Buy
  • Analyst Count
  • GURE 0
  • CHRO 1
  • Target Price
  • GURE N/A
  • CHRO N/A
  • AVG Volume (30 Days)
  • GURE 43.7K
  • CHRO 83.2K
  • Earning Date
  • GURE 05-13-2025
  • CHRO 05-13-2025
  • Dividend Yield
  • GURE N/A
  • CHRO N/A
  • EPS Growth
  • GURE N/A
  • CHRO N/A
  • EPS
  • GURE N/A
  • CHRO N/A
  • Revenue
  • GURE $7,958,395.00
  • CHRO N/A
  • Revenue This Year
  • GURE N/A
  • CHRO N/A
  • Revenue Next Year
  • GURE N/A
  • CHRO N/A
  • P/E Ratio
  • GURE N/A
  • CHRO N/A
  • Revenue Growth
  • GURE N/A
  • CHRO N/A
  • 52 Week Low
  • GURE $0.50
  • CHRO $0.45
  • 52 Week High
  • GURE $1.75
  • CHRO $3.80
  • Technical
  • Relative Strength Index (RSI)
  • GURE 48.34
  • CHRO 53.88
  • Support Level
  • GURE $0.56
  • CHRO $0.90
  • Resistance Level
  • GURE $0.68
  • CHRO $1.06
  • Average True Range (ATR)
  • GURE 0.04
  • CHRO 0.09
  • MACD
  • GURE 0.00
  • CHRO 0.03
  • Stochastic Oscillator
  • GURE 55.38
  • CHRO 95.88

About GURE Gulf Resources Inc. (NV)

Gulf Resources Inc is a holding company engaged in the manufacture and trade of bromine and crude salt, and natural gas; manufactures and sells chemical products used in oil and gas field exploration, oil and gas distribution, oil field drilling, wastewater processing, papermaking chemical agents and inorganic chemicals, and manufactures and sells materials for human and animal antibiotics. It operates in four segments: Bromine, Crude Salt, Chemical Products and Natural Gas. It derives maximum revenue from the Bromine segment which is commonly used in brominated flame retardants, fumigants, water purification compounds, dyes, medicines and disinfectants.

About CHRO Chromocell Therapeutics Corporation

Channel Therapeutics Corp is a clinical-stage biotechnology company developing and commercializing novel, non-opioid, non-addictive therapeutics to alleviate pain. The initial clinical focus is to selectively target the sodium ion channel known as NaV1.7 for the treatment of various types of chronic, visceral pain, acute and chronic eye pain, and post-surgical nerve blocks. Its pipeline includes CC8464 for ISFN and EM and CT2000 for Acute and CHronic Eye Pain-Dry Eye Disease.

Share on Social Networks: